Matti L. Gild

Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression

Mabel Ryder, Matti L. Gild, Tobias M. Hohl et al. · PLoS ONE · 2013 · 134 citations · Full text

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis

Talia L. Fuchs, Anthony J. Nassour, Anthony Glover et al. · The American Journal of Surgical Pathology · 2020 · 76 citations · Full text

Prognostic Evaluation, Surgical Oncology, Proliferative Activity +13

Medullary Thyroid Cancer: Updates and Challenges

Matti L. Gild, Roderick Clifton‐Bligh, Lori J. Wirth et al. · Endocrine Reviews · 2023 · 73 citations · Full text

Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells

Matti L. Gild, Iñigo Landa, Mabel Ryder et al. · Endocrine Related Cancer · 2013 · 66 citations · Full text

Thyroid Cancer Cells, Radiation Oncology, Mtor Kinase Activities +13

Role of <scp>DOTATATE</scp>‐<scp>PET</scp>/<scp>CT</scp> in preoperative assessment of phaeochromocytoma and paragangliomas

Matti L. Gild, Nikita Naik, Jeremy Hoang et al. · Clinical Endocrinology · 2018 · 46 citations